Stefan F T Weiss

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

FEBS open bio

BMC cancer

Expert opinion on therapeutic patents

University of the Witwatersrand

Ruprecht Karls Universität Heidelberg (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of the Witwatersrand Jul 01 2009

South Africa

Professor of Biochemistry

Education History

Ruprecht Karls Universität Heidelberg - Jul 19 2002

Germany

PHD

Publications

Martin Bernert, Monique J Bignoux, Chandni Madhav, Sichumiso Gqeba, Tyrone C Otgaar, Gavin Morris, Stefan F T Weiss, Eloise Ferreira
PLGA nanocapsules as a delivery system for a recombinant LRP-based therapeutic. FEBS open bio (2024)
Martin Bernert, Monique J Bignoux, Chandni Madhav, Sichumiso Gqeba, Tyrone C Otgaar, Gavin Morris, Stefan F T Weiss, Eloise Ferreira
PLGA nanocapsules as a delivery system for a recombinant LRP-based therapeutic. FEBS open bio 14 (7) (2024)
Martin Bernert, Monique J Bignoux, Chandni Madhav, Sichumiso Gqeba, Tyrone C Otgaar, Gavin Morris, Stefan F T Weiss, Eloise Ferreira
PLGA nanocapsules as a delivery system for a recombinant LRP-based therapeutic. FEBS open bio 14 (7) (2024)
Martin Bernert, Monique J Bignoux, Chandni Madhav, Sichumiso Gqeba, Tyrone C Otgaar, Gavin Morris, Stefan F T Weiss, Eloise Ferreira
PLGA nanocapsules as a delivery system for a recombinant LRP-based therapeutic. FEBS open bio 14 (7) (2024)
Martin Bernert, Monique J Bignoux, Chandni Madhav, Sichumiso Gqeba, Tyrone C Otgaar, Gavin Morris, Stefan F T Weiss, Eloise Ferreira
PLGA nanocapsules as a delivery system for a recombinant LRP-based therapeutic. FEBS open bio 14 (7) (2024)
Monique J Bignoux, Tyrone C Otgaar, Martin Bernert, Stefan F T Weiss, Eloise Ferreira
Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. FEBS open bio 13 (2) (2023)
Monique J Bignoux, Tyrone C Otgaar, Martin Bernert, Stefan F T Weiss, Eloise Ferreira
Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. FEBS open bio 13 (2) (2023)
Monique J Bignoux, Tyrone C Otgaar, Martin Bernert, Stefan F T Weiss, Eloise Ferreira
Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. FEBS open bio 13 (2) (2023)
Monique J Bignoux, Tyrone C Otgaar, Martin Bernert, Stefan F T Weiss, Eloise Ferreira
Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. FEBS open bio 13 (2) (2023)
Monique J Bignoux, Tyrone C Otgaar, Martin Bernert, Stefan F T Weiss, Eloise Ferreira
Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. FEBS open bio (2022)
Monique J Bignoux, Tyrone C Otgaar, Martin Bernert, Stefan F T Weiss, Eloise Ferreira
Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. FEBS open bio (2022)
Leila Vania, Gavin Morris, Eloise Ferreira, Stefan F T Weiss
Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells. BMC cancer 21 (1) (2021)
Leila Vania, Gavin Morris, Tyrone C Otgaar, Monique J Bignoux, Martin Bernert, Jessica Burns, Anne Gabathuse, Elvira Singh, Eloise Ferreira, Stefan F T Weiss
Patented therapeutic approaches targeting LRP/LR for cancer treatment. Expert opinion on therapeutic patents 29 (12) (2019)
Leila Vania, Thalia M Rebelo, Eloise Ferreira, Stefan F T Weiss
Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation. BMC cancer 18 (1) (2018)

Stefan F T Weiss.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stefan F T Weiss